These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29635617)

  • 21. Surfactant abnormalities in infants with severe viral bronchiolitis.
    Dargaville PA; South M; McDougall PN
    Arch Dis Child; 1996 Aug; 75(2):133-6. PubMed ID: 8869194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.
    Todd DA; Marsh MJ; George A; Henderson NG; Barr H; Sebastian S; Clark GT; Koster G; Clark HW; Postle AD
    Pediatr Crit Care Med; 2010 Jan; 11(1):82-91. PubMed ID: 19550365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS).
    Robertson B
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):64-9. PubMed ID: 9632910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surfactant inactivation and surfactant replacement in experimental models of ARDS.
    Robertson B
    Acta Anaesthesiol Scand Suppl; 1991; 95():22-8. PubMed ID: 1927224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets.
    Balaraman V; Meister J; Ku TL; Sood SL; Tam E; Killeen J; Uyehara CF; Egan E; Easa D
    Am J Respir Crit Care Med; 1998 Jul; 158(1):12-7. PubMed ID: 9655700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchoalveolar Lavage and Oleic Acid-Injection in Pigs as a Double-Hit Model for Acute Respiratory Distress Syndrome (ARDS).
    Rissel R; Gosling M; Ruemmler R; Ziebart A; Hartmann EK; Kamuf J
    J Vis Exp; 2020 May; (159):. PubMed ID: 32538907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Damage to surfactant-specific protein in acute respiratory distress syndrome.
    Baker CS; Evans TW; Randle BJ; Haslam PL
    Lancet; 1999 Apr; 353(9160):1232-7. PubMed ID: 10217084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Composition and function of pulmonary surfactant in adult respiratory distress syndrome.
    Hallman M; Maasilta P; Sipilä I; Tahvanainen J
    Eur Respir J Suppl; 1989 Mar; 3():104s-108s. PubMed ID: 2662993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective medicated (normal saline and exogenous surfactant) bronchoalveolar lavage in severe aspiration syndrome in children.
    Marraro GA; Luchetti M; Spada C; Galassini E; Giossi M; Piero AM
    Pediatr Crit Care Med; 2007 Sep; 8(5):476-81. PubMed ID: 17693914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
    Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
    Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of mechanisms of surfactant inhibition.
    Gunasekara L; Schoel WM; Schürch S; Amrein MW
    Biochim Biophys Acta; 2008 Feb; 1778(2):433-44. PubMed ID: 18036553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome.
    Dushianthan A; Goss V; Cusack R; Grocott MP; Postle AD
    Respir Res; 2014 Nov; 15(1):128. PubMed ID: 25378080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of granulocyte activation by surfactant in a 2-yr-old female with meningococcus-induced ARDS.
    Tegtmeyer FK; Möller J; Zabel P
    Eur Respir J; 2002 Apr; 19(4):776-9. PubMed ID: 11999008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome.
    Zhu GF; Sun B; Niu SF; Cai YY; Lin K; Lindwall R; Robertson B
    Am J Respir Crit Care Med; 1998 Aug; 158(2):437-43. PubMed ID: 9700118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surfactant alteration and replacement in acute respiratory distress syndrome.
    Günther A; Ruppert C; Schmidt R; Markart P; Grimminger F; Walmrath D; Seeger W
    Respir Res; 2001; 2(6):353-64. PubMed ID: 11737935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives for use of surfactant in children and adults.
    Marraro GA
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():29-31. PubMed ID: 15590431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome.
    Lachmann B
    Eur Respir J Suppl; 1989 Mar; 3():98s-103s. PubMed ID: 2663002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchoalveolar lavage with diluted porcine surfactant in mechanically ventilated term infants with meconium aspiration syndrome.
    Lista G; Bianchi S; Castoldi F; Fontana P; Cavigioli F
    Clin Drug Investig; 2006; 26(1):13-9. PubMed ID: 17163230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung Lavage and Surfactant Replacement During Ex Vivo Lung Perfusion for Treatment of Gastric Acid Aspiration-Induced Donor Lung Injury.
    Nakajima D; Liu M; Ohsumi A; Kalaf R; Iskender I; Hsin M; Kanou T; Chen M; Baer B; Coutinho R; Maahs L; Behrens P; Azad S; Martinu T; Waddell TK; Lewis JF; Post M; Veldhuizen RAW; Cypel M; Keshavjee S
    J Heart Lung Transplant; 2017 May; 36(5):577-585. PubMed ID: 28041954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant subtypes in experimental lung damage: radiation pneumonitis.
    Gross NJ
    Am J Physiol; 1991 Apr; 260(4 Pt 1):L302-10. PubMed ID: 2018150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.